GHS Cancer Institute is a clinical research site located in Seneca, South Carolina, United States 29672.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
GHS Cancer Institute has participated in 2 clinical trials.
Therapeutic areas: Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Squamous Cell Carcinoma of the Head and Neck.
Sponsors: Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in South Carolina · View every site in Seneca
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
GHS Cancer Institute has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GHS Cancer Institute has 2 clinical trials on record. Their work covers Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Squamous Cell Carcinoma of the Head and Neck.
GHS Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.